Magnesium and its alloys have the potential to serve as a revolutionary class of biodegradable materials, specifically in the field of degradable implants for orthopedics. However, the corrosion rate of commercially pure magnesium is high and does not match the rate of regeneration of bone tissues. In this work, magnesium alloys containing zinc and cerium, either alone or in combination, were investigated and compared with commercially-pure magnesium as biomaterials. The microstructure, mechanical properties, corrosion resistance, and response of osteoblasts in vitro were systematically assessed. Results reveal that alloying with Ce results in grain refinement and weakening of texture. The tensile test revealed that the ternary alloy offered the best combination of elastic modulus (41.1 ± 0.5 GPa), tensile strength (234.5 ± 4.5 MPa), and elongation to break (17.1 ± 0.4%). The ternary alloy was also the most resistant to corrosion (current of 0.85 ± 0.05 × 10−4 A cm−2) in simulated body fluid than the other alloys. The response of MC3T3-E1 cells in vitro revealed that the ternary alloy imparts minimal cytotoxicity. Interestingly, the ternary alloy was highly efficient in supporting osteogenic differentiation, as revealed by the expression of alkaline phosphatase and calcium deposition. In summary, the extruded Mg alloy containing both Zn and Ce exhibits a combination of mechanical properties, corrosion resistance, and cell response that is highly attractive for engineering biodegradable orthopedic implants.
There is an increasing need to develop simplified
in vitro
platforms that mimic the tissue environment to understand cardiovascular and musculoskeletal diseases. Towards this objective, we first explored different surface engineering strategies for culturing cardiomyocytes, which could be used for investigating disease conditions like cardiac hypertrophy. Firstly, we investigated the possibility of using human hair derived keratin as a simple, efficient and cost-effective substrate for culturing cardiomyocytes. Cardiomyocytes grown on keratin expressed cardiac specific markers and displayed spontaneous contraction. We further evaluated the development of cardiomyocyte hypertrophy upon treatment with the agonist, phenylephrine. We observed the induction of hypertrophy at the transcriptional as well as signaling level. We also observed a marked increase in protein synthesis in these cells indicating the development of hypertrophy. Next, we employed microscale topography to confine cardiomyocytes along ridges which closely resembles mammalian heart. Cardiomyocytes grown on micro-ridges showed global alignment and elliptical nuclear morphology. Calcium currents traversed the cardiomyocytes in a directional manner and were also responsive to hypertrophic stimuli. Like cardiomyocytes, we also investigated the effect of aligned topography on primary myoblasts using nanofibers. These nanofibers retained the myotubes in culture for longer duration as compared to myotubes formed on flat surfaces. Recently, we have seen that once the myoblasts grown on flat surfaces become confluent they spontaneously differentiate to form myotubes even in the absence of differentiation cues. However, myoblasts grown on aligned fibers remain in their undifferentiated state and differentiate only upon induction with differentiation media. These results highlight the suitability of using keratin for cardiomyocyte culture and also emphasize the importance of topography in assessing cardiac and musculoskeletal function. We propose that studies which take into account the morphology of the cells offer greater potential towards clinical translation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.